Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2021-09-04 Regulatory Filings
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Regulatory Filings
2021-09-04 English
News release - English.pdf
Regulatory Filings
2021-08-27 English
News release - English.pdf
Regulatory Filings
2021-08-24 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of a secured debt financing transaction by Avicanna Inc. It details the terms of the loan, the issuance of warrants, regulatory approvals, and background information about the company. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is an update on financing activity rather than a full financial report or regulatory filing. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and content support this classification with high confidence.
2021-08-19 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a partnership agreement between Avicanna Inc. and Heritage Cannabis Holdings Corp. for the commercialization of CBD topical products. It details the terms of the licensing agreement, product descriptions, company backgrounds, and forward-looking statements. There are no financial statements, regulatory filings, voting results, or management changes. The content is focused on a business partnership and commercialization strategy rather than financial results or regulatory compliance. This type of announcement fits best under Capital/Financing Update (CAP) as it relates to a strategic commercial partnership and licensing agreement impacting the company's business and revenue streams.
2021-08-11 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a partial revocation of a cease trade order by the Ontario Securities Commission and a proposed financing by Avicanna Inc. It details the terms of a secured debenture financing, issuance of warrants, and the intended use of proceeds. The document is not a financial report, audit, or earnings release but rather an update on capital raising activities and regulatory status. It includes no financial statements or detailed financial analysis but focuses on the financing terms and regulatory approvals. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed financing information, supporting a high confidence in classification.
2021-08-03 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.